Abstract
Posttraumatic stress disorder (PTSD) is a chronic anxiety disorder caused by seeing or experiencing traumatic events. The symptoms of PTSD lead to clinically significant distress, functional impairment, and suicide. Although multiple populations suffer from PTSD symptoms, this chapter focuses on military population. Recent wars have led to a large number of military personal having multiple and severe symptoms of psychological distress. This increase has been punctuated by reports of extremely high suicide rate. While advances have been made in understanding and treating this syndrome, barriers to their care continue to exist among military personnel; namely the stigma attached to having a mental health issue and the difficulty finding a treatment regimen that works. This chapter focuses on a veteran who presented with severe PTSD and active suicidal ideations seeking to be treated by cervical sympathetic blockade. His story of previous treatment history, severity of symptoms, and the need to find a clinician outside the conventional military providers demonstrates the urgent need for a system-wide change.
The veteran described above was treated by the author with stellate ganglion block (SGB) two days after presenting for care and had resolution of suicidal ideation 30 min following the procedure. He had the SGB treatment repeated one time 16 days after SGB #1. Four years after completing the treatment, the patient was doing well as defined by a marked reduction in psychiatric measures, as well as self-report. The SGB has traditionally been used to treat chronic pain and has recently been reported as a successful treatment of PTSD symptoms by four military institutions (Walter Reed National Military Medical Center, Long Beach (California), Tripler Army Medical Center (Hawaii), Naval Medical Center (San Diego)). Cervical sympathetic blockade involves injecting a local anesthetic next to a group of nerves (ganglion) in the neck and has been used clinically since 1925 with very few side effects. Finally, the neurobiology of SGB is discussed and the future direction of the sympathetic system modulation as a treatment option for PTSD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
PTSD VA. http://www.ptsd.va.gov/professional/PTSD-overview/ptsd-overview.asp. Accessed 16 Nov 2014.
Da Costa JM. On irritable heart; a clinical study of a form of functional cardiac disorder and its consequences. Am J Med Sci. 1871;121(1):2–52.
http://www.wired.com/2010/07/obama-loves-this-freaky-ptsd-treatment-the-pentagon-not-so-much/Accessed 15 May 2012.
Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD checklist (PCL). Behav Res Ther. 1996;34:669–73.
Bliese PD, Wright KM, Adler AB, et al. Validating the primary care posttraumatic stress disorder screen and the posttraumatic stress disorder checklist with soldiers returning from combat. J Consult Clin Psychol. 2008;76:272–81.
Forbes D, Creamer M, Biddle D. The validity of the PTSD checklist as a measure of symptomatic change in combat-related PTSD. Behav Res Ther. 2001;39:977–86.
Gore AT, Richards-Reid GM. Posttraumatic stress disorder. 2006. eMedicine [serial online]. http://www.emedicine.com/med/topic1900.htm. Accessed 21 Oct 2007.
Institute of Medicine. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, DC: National Academies; 2007.
Hoge CW. Interventions for war-related posttraumatic stress disorder: meeting veterans where they are. JAMA. 2011;306:549–51.
Balon R. SSRI-associated sexual dysfunction. Am J Psychiatr 2006;163:1504–163.
Giner L, Nichols CM, Zalsman G, et al. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update. Int J Adolesc Med Health. 2005;17:211–7.
Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatr. 2007;61(8):928–34.
Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial. JAMA. 2000;283:1837–283.
Zohar J, Amital D, Miodownik C, et al. Double-blind placebo controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol. 2002;22:190.
Scott L. http://www.vawatchdog.org/10/nf10/nfaug10/nf083110-1.htm at VA Watchdog dot Org 08-31-2010. Accessed 22 Feb 2014.
Jones E, Wessely S. Shell shock to PTSD: military psychiatry from 1900 to the Gulf War 2005. Hove: Taylor & Francis. 2006; ISSN 0076–5465.
http://www.nolo.com/legal-encyclopedia/seroquel-product-liability-claims-32525.html. Accessed 23 Jan 2015.
Schneeweiss S, Avorn J. Antipsychotic agents and sudden cardiac death—how should we manage the risk? N Engl J Med. 2009;360:294–6.
Kuehn BM. FDA panel issues mixed decision on quetiapine in depression and anxiety. JAMA. 2009;301(20):2081–2.
Herings RM, Erkens JA, Increased suicide attempt rate among patients interrupting use of atypical antipsychotics. Pharmacoepidem Drug Safe. 2003; 12: 423–4.
Paunovic N, Öst LG. Cognitive-behavior therapy vs exposure therapy in the treatment of PTSD in refugees. Behav Res Ther. 2001;39(10):1183–97.
Shapiro F. Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories. J Trauma Stress. 1989;2:199–223.
Bisson J, Andrew M. Psychological treatment of Posttraumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2007.
Salkovskis P. Review: eye movement desensitization and reprocessing is not better than exposure therapies for anxiety or trauma. Evid-Based Ment Health. 2002;5(1):13.
Watts BV, Schnurr PP, Mayo L, et al. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatr. 2013;74:e541–50.
Meyer JS. 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Subst Abuse Rehabil,2013;4:83–99.
Parrott AC. The potential dangers of using MDMA for psychotherapy. J Psychoact Drugs. 2014;46(1):37–43.
Streeter CC, Gerbarg RB, Saper DA, et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and Posttraumatic stress disorder. Med Hypotheses. 2012;78(5):571–9.
Kearney DJ, McDermott K, Malte C, et al. Association of participation in a mindfulness program with measures of PTSD, depression and quality of life in a veteran sample. J Clin Psychol. 2012;68(1):101–16.
Hölzel BK, Carmody J, Evans KC, et al. Stress reduction correlates with structural changes in the amygdala. Soc Cogn Affect Neurosci. 2009;5:11–7.
Lipov EG, Joshi JR, et al. A unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD). Med Hypotheses. 2009;72(6):657–61.
Southwick SM, Bremner JD, Rasmusson A, et al. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatr. 1999;46:1192–204.
Mason JW, Giller EL, Kosten TR, et al. Elevation of urinary norepinephrine/cortisol ratio in posttraumatic stress disorder. J Nerv Ment Dis. 1988;176:498–502.
Geracioti TD, Baker DG, Ekhator NN, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatr. 2001;158:1227–158.
Taylor FB, Lowe K, Thompson C, et al. Daytime Prazosin reduces psychological distressto trauma specific cuesin civilian trauma post traumatic stress disorder . Biol Psychiatr. 2006;59:577–81.
Ma D, Rajakumaraswamy N, Maze M. Alpha2-adrenoceptor agonists: shedding light on neuroprotection? Br Med Bull. 2004;71:77–92.
Sutherland SM, Davidson JR. Pharmacotherapy for Posttraumatic stress disorder. Psychiatr Clin North Am. 1994;17:409–23.
Uchida K, Tateda T, et al. Novel mechanism of action hypothesized for stellate ganglion block related to melatonin. Med Hypotheses. 2002;59:446–9.
Westerhaus MJ, Loewy AD. Central representation of the sympathetic nervous system in the cerebral cortex. Brain Res. 2001;903:117–27.
Telaranta T. Treatment of social phobia by endoscopic thoracic sympathicotomy. Eur J Surg Suppl. 1998;580:27–32.
Telaranta T. Psychoneurological applications of endoscopic sympathetic blocks (ESB) [invited lecture]. Clin Auton Res. 2003;13(Suppl. 1):I120–1.
Lipov EG, Joshi JR, Lipov SG, Sanders SE, Siroko MK. Cervical sympathetic blockade in a patient with posttraumatic stress disorder: a case report. Ann Clin Psychiatry. 2008;20:227–8.
Wulf H, Maier CH. Complications of stellate ganglion blockade: results of a survey. Anaesthetist. 1992;41:146–51.
Navaie M, Keefe MS, Hickey AH, et al. Use of stellate ganglion block for refractory Posttraumatic stress disorder: a review of published cases. J Anesth Clin Res. 2014 5(403):2.
Alino J, Kosatka D, McLean B, et al. Efficacy of stellate ganglion block in the treatment of anxiety symptoms from combat-related Posttraumatic stress disorder: a case series. Mil Med, 2013;178:473–7.
Mulvaney SW, McLean B, De Leeuw J. The use of stellate ganglion block in the treatment of panic/anxiety symptoms with combat-related Posttraumatic stress disorder; preliminary results of long-term follow- up: a case series. Pain Pract. 2010;10:349–65.
Mulvaney SW, Lynch JH, Hickey MJ, et al. Stellate ganglion block used to treat symptoms associated with combat-related post-traumatic stress disorder: a case series of 166 patients. Mil Med. 2014;179(10):1133–40.
Alkire MT, Hollifield M, Khoshsar R, et al. Prolonged relief of chronic extreme PTSD and depression symptoms in veterans following a stellate ganglion block. Presented at American Society of Anesthesiology. 11 Oct 2014.
Hickey AH, Hanling S, Pevney E, et al. Stellate ganglion block for PTSD. Am J Psychiatry. 2012;169:760.
Liberzon I, Martis B. Neuroimaging studies of emotional responses in PTSD. Ann N Y Acad Sci. 2006;1071:87–109.
Alleva E, Petruzzi S, Cirulli F, et al. NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav. 1996;54:65–72.
Smith MA. Hippocampal vulnerability to stress and aging: possible role of neurotrophic factors. Behav Brain Res. 1996;78:25–36.
Isaacson LG, Billieu SC. Increased perivascular norepinephrine following intracerebroventricular infusion of NGF into adult rats. Exp Neurol. 1996;139(1):54–60.
Morilak DA, Barrera G, Echevarria D J, et al. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatr. 2005;29(8):1214–24.
Johnson EM Jr, Taniuchi M, Clark HB, et al. Demonstration of the retrograde transport of nerve growth factor receptor in the peripheral and central nervous system. J Neurosci. 1987;7:923–5.
Chen PS, Chen LS, Cao JM, Sharifi B, Karagueuzian HS, Fishbein MC. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res. 2001;50(2):409–16.
Madison R, Davis JN. Sprouting of noradrenergic fibers in hippocampus after medial septal lesions: contributions of the central and peripheral nervous systems. Exp Neurol. 1983;80(1):167–77.
Takatori T, Kuroda Y, Hirose M. Local anesthetics suppress nerve growth factor-mediated neurite outgrowth by inhibition of tyrosine kinase activity of TrkA. Anesth Analg. 2006;102:462–7.
Gatzinsky KP, Thrasivoulou C, Campioni-Noack M, Underwood C, Cowen T. The role of NGF uptake in selective vulnerability to cell death in ageing sympathetic neurons. Eur J Neurosci. 2004;20(11):2848–56.
Jeong S, Jeon Y, Yeo J, Baek W. The effects of stellate ganglion block on the electroencephalogram in rats. J Anesth. 2014:28(4):601–5.
Bogduk N. Complex regional pain syndrome. Curr Opin Anaesth. 2001;14:541–6.
Van Eijs F, Stanton‐Hicks M, Van Zundert J, et al. Complex regional pain syndrome. Pain Pract. 2011;11(1):70–87.
Maihöfner C, Forster C, Birklein F, et al. Brain processing during mechanical hyperalgesia in complex regional pain syndrome: a functional MRI study. Pain. 2005;114(1–2):93–103.
Liberzon I, Martis B. Neuroimaging studies of emotional responses in PTSD. Ann N Y Acad Sci. 2006;1071(1):87–109.
Grande LA, Loeser JD, Ozuna J, et al. Complex regional pain syndrome as a stress response. Pain 2004;110(1–2):495–8.
Schore AN. Dysregulation of the right brain: a fundamental mechanism of traumatic attachment and the psychopathogenesis of posttraumatic stress disorder. Aust N Z J Psychiatr. 2002;36(1):9–30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lipov, E. (2015). The Use of Stellate Ganglion Block in the Treatment of Panic/Anxiety Symptoms (Including Suicidal Ideation), with Combat-Related Posttraumatic Stress Disorder. In: Ritchie, E. (eds) Posttraumatic Stress Disorder and Related Diseases in Combat Veterans. Springer, Cham. https://doi.org/10.1007/978-3-319-22985-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-22985-0_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-22984-3
Online ISBN: 978-3-319-22985-0
eBook Packages: MedicineMedicine (R0)